查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1565661

週期性发烧综合症市场，按产品类型、治疗方法、分布、年龄组、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Periodic Fever Syndrome Market, By Product Type, By Treatment, By Distribution, By Age Group, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023 年週期性发烧症候群市场规模为 6.209 亿美元，2024 年至 2032 年复合年增长率为 4.80%。

週期性发烧综合症市场-市场动态

遗传性疾病的日益普及导致对週期性发烧症候群的需求

遗传性疾病的日益流行正在推动对週期性发烧综合症 (PFS) 等疾病的有效治疗的需求不断增加。随着越来越多的人被诊断出患有与自体发炎性疾病相关的基因突变，例如家族性地中海热、高免疫球蛋白D 综合征和TNF 受体相关週期性综合征(TRAPS)，对专门医疗干预措施的需求不断增加。週期性发烧综合症的特征是反覆发烧和全身炎症，如果不及时治疗，可能会严重影响患者的生活品质。遗传性疾病病例的增加提高了医疗保健专业人员和研究人员的认识，推动先进的诊断工具和疗法来应对 PFS 带来的独特挑战。根据世界卫生组织统计，全球每年估计有 24 万名新生儿在出生后 28 天内死于先天性疾病。先天性疾病导致另外 17 万名 1 个月至 5 岁的儿童死亡。因此，製药和生物技术部门正在努力开发创新疗法来管理和减轻与这些疾病相关的症状，旨在改善患者的治疗结果并减轻整体疾病负担。

週期性发烧综合症市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 4.80% 左右的复合年增长率成长

根据产品类型细分，预计遗传性週期性发烧症候群将在 2023 年呈现最大市场份额

根据治疗细分，药物是 2023 年的主导类型

从分布细分来看，医院药局是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

週期性发烧综合症市场-細項分析：

全球週期性发烧综合症市场根据产品类型、治疗、分布、年龄层和地区进行细分。

根据产品类型，市场分为两类：遗传性週期性发烧综合症和后天性週期性发烧综合症。医疗保健专业人员和患者意识的提高导致了诊断率的提高。有了更好的诊断工具（包括基因检测），更多的人被识别出患有 HPFS。先进治疗方案的开发，特别是白细胞介素 (IL)-1 抑制剂（例如阿那白滞素和卡那奴单抗）等生物製剂，改善了治疗结果。这些创新疗法提供更有效的症状管理，进而提高采用率。

根据治疗方法，市场分为四类：药物、基因治疗、症状治疗和其他新兴疗法。基因疗法提供了解决 PFS 潜在遗传原因的标靶治疗的潜力。由于许多 PFS 病症是由特定基因突变引起的，因此基因疗法可以直接纠正这些突变或调节相关基因的表达。总体而言，标靶治疗潜力、技术进步以及支持性研究和监管环境的结合有助于基因治疗在週期性发烧综合症市场中占据较高的市场份额。

週期性发烧综合症市场 - 地理洞察

由于人们对罕见遗传疾病的认识不断提高、诊断工具的进步和治疗方案的改进，北美週期性发烧综合症市场正在经历显着增长。美国凭藉完善的医疗基础设施、大型製药公司的存在以及受益于先进疗法的患者人数不断增长而在市场上占据主导地位。加拿大也发挥关键作用，不断扩大研究计画并增加对罕见疾病治疗的投资。美国食品药物管理局 (FDA) 和加拿大卫生部的监管支持促进了新疗法的批准，进一步加速了该地区的市场成长。

週期性发烧综合症市场-竞争格局：

週期性发烧综合症（PFS）市场的特征是存在专注于罕见疾病和孤儿药的主要製药公司。主要参与者包括诺华 (Novartis)、瑞典孤儿 Biovitrum (Sobi) 和再生元製药 (Regeneron Pharmaceuticals)。诺华透过其生物疗法 Ilaris（canakinumab），透过治疗各种 PFS 亚型（包括隐热蛋白相关週期性症候群 (CAPS)），占据了重要的市场份额。 Sobi 非常重视免疫学和罕见疾病治疗，其产品 Kineret（阿那白滞素）在解决 PFS 方面也发挥着至关重要的作用。 Regeneron 以其在发炎性疾病方面的作用而闻名，提供了 Dupixent (dupilumab)，可用于探索 PFS。专注于利基治疗的小型生物製药公司进一步推动了市场，并不断研究和开发新疗法。竞争是由创新、疗效和获得孤儿药指定的机会所推动的，从而在这个罕见疾病市场中创造了一个充满活力的环境。

最新进展：

2020 年 6 月，美国国立卫生研究院下属的国家人类基因组研究所 (NHGRI) 的研究人员发现了仅影响儿童的反覆非传染性发烧和疮的可能原因的线索。有些基因与这种称为 PFAPA 症候群的症候群有关，可能会带来新的治疗方法。

2020 年 9 月，诺华宣布美国食品药物管理局 (FDA) 同时批准三项批准扩大 Ilaris (canakinumab) 的用途，用于治疗三种罕见且不同类型的周期性发烧症候群。

目录

第一章：週期性发烧症候群市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 依产品类型分類的周期性发烧综合症市场片段
    • 週期性发烧综合症治疗市场片段
    • 週期性发烧综合症市场片段（依分布）
    • 依年龄层分類的周期性发烧综合症市场片段
    • 按国家/地区分類的周期性发烧综合症市场片段
    • 按地区分類的周期性发烧综合症市场片段
  • 竞争洞察

第 3 章：週期性发烧症候群主要市场趋势

  • 週期性发烧综合症市场驱动因素
    • 市场驱动因素的影响分析
  • 週期性发烧症候群市场限制
    • 市场限制影响分析
  • 週期性发烧症候群市场机会
  • 週期性发烧症候群市场未来趋势

第 4 章：週期性发烧症候群产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：週期性发烧综合症市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：週期性发烧综合症市场格局

  • 週期性发烧综合症市场份额分析，2023 年
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：週期性发烧综合症市场 - 依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 遗传性週期性发烧综合症
      • 家族性地中海热 (FMF)
      • 高免疫球蛋白血症 D 症候群 (HIDS)
      • 肿瘤坏死因子受体相关週期性症候群 (TRAPS)
    • 后天性週期性发烧综合症
      • 週期性发烧、口疮性口炎、咽炎、腺炎 (PFAPA)
      • 其他非遗传性週期性发烧综合症

第 8 章：週期性发烧症候群市场 - 依治疗分类

  • 概述
    • 按处理方式分類的细分市场占有率分析
    • 药物
    • 基因治疗
    • 症状治疗
    • 其他新兴疗法

第 9 章：週期性发烧症候群市场 - 按分布

  • 概述
    • 按分布分類的细分市场占有率分析
    • 医院药房
    • 零售药局
    • 网路药局
    • 专科诊所

第 10 章：週期性发烧综合症市场 - 按年龄组

  • 概述
    • 按处理方式分類的细分市场占有率分析
    • 儿科患者
    • 成人患者

第 11 章：週期性发烧症候群市场 - 依地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 週期性发烧综合症北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模与预测（以不同处理方式）
    • 北美市场规模和预测（按分布）
    • 北美市场规模和预测（按年龄组）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲週期性发烧综合症主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模与预测（按处理方式）
    • 欧洲市场规模和预测（按分布）
    • 欧洲市场规模和预测（按年龄层）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 週期性发烧综合症亚太地区主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（以不同处理方式）
    • 亚太地区市场规模与预测（按分布）
    • 亚太地区市场规模与预测（依年龄层）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲週期性发热症候群主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（以不同处理方式）
    • 拉丁美洲市场规模与预测（按分布）
    • 拉丁美洲市场规模与预测（按年龄层）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲週期性发烧症候群主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东及非洲市场规模及预测（依不同处理方式）
    • 中东和非洲市场规模及预测（按分布）
    • 中东和非洲市场规模及预测（按年龄层）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 週期性发烧综合症行业

  • 竞争仪表板
  • 公司简介
    • Novartis AG
    • Swedish Orphan Biovitrum AB (Sobi)
    • Regeneron Pharmaceuticals, Inc.
    • Pfizer Inc.
    • Horizon Therapeutics plc
    • Takeda Pharmaceutical Company Ltd.
    • AbbVie Inc.
    • Eli Lilly and Company
    • Amgen Inc.
    • Sanofi SA
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV3857

REPORT HIGHLIGHT

Periodic Fever Syndrome Market size was valued at USD 620.90 million in 2023, expanding at a CAGR of 4.80% from 2024 to 2032.

The Periodic Fever Syndrome market focuses on treatments for a group of rare autoinflammatory disorders characterized by recurrent episodes of fever and inflammation, including Familial Mediterranean Fever (FMF), TNF receptor-associated periodic syndrome (TRAPS), and Hyper-IgD syndrome (HIDS). The market is driven by advances in genetic research, which help in early diagnosis and personalized treatment options. Key therapeutic approaches include biologics, such as interleukin-1 inhibitors and TNF inhibitors, offering relief from symptoms and reducing flare-ups. Increased awareness among healthcare professionals and rising patient support initiatives also support market growth. Major players include Novartis, Sobi, and Pfizer, contributing to drug development and clinical trials aimed at addressing these disorders more effectively.

Periodic Fever Syndrome Market- Market Dynamics

Growing Prevalence of Genetic Disorders Leading the Need for Periodic Fever Syndrome

The growing prevalence of genetic disorders is driving an increased demand for effective treatments for conditions like Periodic Fever Syndrome (PFS). As more individuals are diagnosed with genetic mutations linked to autoinflammatory diseases, such as familial Mediterranean fever, hyperimmunoglobulin D syndrome, and TNF receptor-associated periodic syndrome (TRAPS), the need for specialized medical interventions has escalated. Periodic Fever Syndrome, characterized by recurrent fevers and systemic inflammation, can significantly impact patients' quality of life if left untreated. This rise in genetic disorder cases has heightened awareness among healthcare professionals and researchers, pushing for advanced diagnostic tools and therapies to address the unique challenges posed by PFS. According to the World Health Organization, an estimated 240,000 newborns die worldwide within 28 days of birth every year due to congenital disorders. Congenital disorders cause a further 170,000 deaths of children between the ages of 1 month and 5 years. Consequently, the pharmaceutical and biotechnology sectors are working towards developing innovative treatments to manage and alleviate the symptoms associated with these conditions, aiming to improve patient outcomes and reduce the overall disease burden.

Periodic Fever Syndrome Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.80% over the forecast period (2024-2032)

Based on product type segmentation, Hereditary Periodic Fever Syndromes was predicted to show maximum market share in the year 2023

Based on treatment segmentation, Medications was the leading type in 2023

Based on distribution segmentation, Hospital Pharmacies was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Periodic Fever Syndrome Market- Segmentation Analysis:

The Global Periodic Fever Syndrome Market is segmented on the basis of Product Type, Treatment, Distribution, Age Group, and Region.

The market is divided into two categories based on product type: Hereditary Periodic Fever Syndromes, and Acquired Periodic Fever Syndromes. Increased awareness among healthcare professionals and patients has led to higher diagnosis rates. With better diagnostic tools, including genetic testing, more individuals are being identified with HPFS. The development of advanced therapeutic options, particularly biologics like interleukin (IL)-1 inhibitors (e.g., anakinra and canakinumab), has improved treatment outcomes. These innovative treatments offer more effective symptom management, leading to higher adoption.

The market is divided into four categories based on treatment: Medications, Gene Therapy, Symptomatic Treatment, and Other Emerging Therapies. Gene therapy offers the potential for targeted treatments that address the underlying genetic causes of PFS. Since many PFS conditions are caused by specific genetic mutations, gene therapy can directly correct these mutations or modulate the expression of the genes involved. Overall, the combination of targeted treatment potential, technological advancements and supportive research and regulatory environments contribute to the high market share of gene therapy in the Periodic Fever Syndrome market.

Periodic Fever Syndrome Market- Geographical Insights

The Periodic Fever Syndrome market in North America is experiencing notable growth, driven by an increasing awareness of rare genetic conditions, advancements in diagnostic tools, and improved treatment options. The United States dominates the market due to a well-established healthcare infrastructure, the presence of major pharmaceutical companies, and a growing patient population benefiting from advanced therapies. Canada also plays a key role, with expanding research initiatives and rising investment in rare disease treatments. Regulatory support from the U.S. Food and Drug Administration (FDA) and Health Canada has facilitated the approval of new treatments, further accelerating market growth in the region.

Periodic Fever Syndrome Market- Competitive Landscape:

The Periodic Fever Syndrome (PFS) market is characterized by the presence of key pharmaceutical companies focusing on rare diseases and orphan drugs. Major players include Novartis, Swedish Orphan Biovitrum (Sobi), and Regeneron Pharmaceuticals. Novartis, through its biologic therapy Ilaris (canakinumab), holds a significant market share by treating a variety of PFS subtypes, including Cryopyrin-Associated Periodic Syndromes (CAPS). Sobi, with its strong emphasis on immunology and rare disease therapies, also plays a crucial role in addressing PFS with its product Kineret (anakinra). Regeneron, known for its work in inflammatory diseases, offers Dupixent (dupilumab), which can be explored for PFS. The market is further bolstered by smaller biopharmaceutical companies focusing on niche treatments, with ongoing research and development for novel therapies. Competition is driven by innovation, efficacy, and access to orphan drug designations, creating a dynamic environment in this rare disease market.

Recent Developments:

In June 2020, Researchers at the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, discovered clues to the possible cause of recurring, non-contagious fevers and sores that affect only children. Several genes have been implicated with the syndrome, known as PFAPA syndrome which could lead to new treatments.

In September 2020, Novartis announced that the US Food and Drug Administration (FDA) has granted three simultaneous approvals for the expanded use of Ilaris (canakinumab) to treat three rare and distinct types of Periodic Fever Syndromes.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERIODIC FEVER SYNDROME MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Novartis AG
  • Swedish Orphan Biovitrum AB (Sobi)
  • Regeneron Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Horizon Therapeutics plc
  • Takeda Pharmaceutical Company Ltd.
  • AbbVie Inc.
  • Eli Lilly and Company
  • Amgen Inc.
  • Sanofi S.A.
  • Others

GLOBAL PERIODIC FEVER SYNDROME MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Hereditary Periodic Fever Syndromes
  • Familial Mediterranean Fever (FMF)
  • Hyperimmunoglobulinemia D Syndrome (HIDS)
  • Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS)
  • Acquired Periodic Fever Syndromes
  • Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA)
  • Other Non-Hereditary Periodic Fever Syndromes

GLOBAL PERIODIC FEVER SYNDROME MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032

  • Medications
  • Gene Therapy
  • Symptomatic Treatment
  • Other Emerging Therapies

GLOBAL PERIODIC FEVER SYNDROME MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Specialty Clinics

GLOBAL PERIODIC FEVER SYNDROME MARKET, BY AGE GROUP - MARKET ANALYSIS, 2019 - 2032

  • Pediatric Patients
  • Adult Patients

GLOBAL PERIODIC FEVER SYNDROME MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Periodic Fever Syndrome Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Periodic Fever Syndrome Market Snippet by Product Type
    • 2.1.2. Periodic Fever Syndrome Market Snippet by Treatment
    • 2.1.3. Periodic Fever Syndrome Market Snippet by Distribution
    • 2.1.4. Periodic Fever Syndrome Market Snippet by Age Group
    • 2.1.5. Periodic Fever Syndrome Market Snippet by Country
    • 2.1.6. Periodic Fever Syndrome Market Snippet by Region
  • 2.2. Competitive Insights

3. Periodic Fever Syndrome Key Market Trends

  • 3.1. Periodic Fever Syndrome Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Periodic Fever Syndrome Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Periodic Fever Syndrome Market Opportunities
  • 3.4. Periodic Fever Syndrome Market Future Trends

4. Periodic Fever Syndrome Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Periodic Fever Syndrome Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Periodic Fever Syndrome Market Landscape

  • 6.1. Periodic Fever Syndrome Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Periodic Fever Syndrome Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Hereditary Periodic Fever Syndromes
      • 7.1.2.1. Familial Mediterranean Fever (FMF)
      • 7.1.2.2. Hyperimmunoglobulinemia D Syndrome (HIDS)
      • 7.1.2.3. Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS)
    • 7.1.3. Acquired Periodic Fever Syndromes
      • 7.1.3.1. Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA)
      • 7.1.3.2. Other Non-Hereditary Periodic Fever Syndromes

8. Periodic Fever Syndrome Market - By Treatment

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
    • 8.1.2. Medications
    • 8.1.3. Gene Therapy
    • 8.1.4. Symptomatic Treatment
    • 8.1.5. Other Emerging Therapies

9. Periodic Fever Syndrome Market - By Distribution

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution, 2023 & 2032 (%)
    • 9.1.2. Hospital Pharmacies
    • 9.1.3. Retail Pharmacies
    • 9.1.4. Online Pharmacies
    • 9.1.5. Specialty Clinics

10. Periodic Fever Syndrome Market - By Age Group

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
    • 10.1.2. Pediatric Patients
    • 10.1.3. Adult Patients

11. Periodic Fever Syndrome Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Periodic Fever Syndrome Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Periodic Fever Syndrome Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Periodic Fever Syndrome Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Periodic Fever Syndrome Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Periodic Fever Syndrome Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Periodic Fever Syndrome Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Novartis AG
    • 12.2.2. Swedish Orphan Biovitrum AB (Sobi)
    • 12.2.3. Regeneron Pharmaceuticals, Inc.
    • 12.2.4. Pfizer Inc.
    • 12.2.5. Horizon Therapeutics plc
    • 12.2.6. Takeda Pharmaceutical Company Ltd.
    • 12.2.7. AbbVie Inc.
    • 12.2.8. Eli Lilly and Company
    • 12.2.9. Amgen Inc.
    • 12.2.10. Sanofi S.A.
    • 12.2.11. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us